Nitroblue tetrazolium reduction in eosinophil granulocytes after treatment with diethylcarbamazine.
D004049:Diethylcarbamazine / Q000494:pharmacology / Q000627:therapeutic use*; D004802:Eosinophilia / Q000097:blood / Q000188:drug therapy*; D004804:Eosinophils / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007958:Leukocyte Count; D009580:Nitroblue Tetrazolium / Q000378:metabolism; D010084:Oxidation-Reduction; D010272:Parasitic Diseases / Q000097:blood / Q000188:drug therapy*
D009580:Nitroblue Tetrazolium; D004049:Diethylcarbamazine